KSE - Delayed Quote KRW

SK Biopharmaceuticals Co., Ltd. (326030.KS)

92,100.00
+100.00
+(0.11%)
At close: 3:30:23 PM GMT+9

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 144.38B
Earnings --

Q2'24

Q3'24

Q4'24

Q1'25

0
50B
100B
150B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

70,000.00 Low
139,062.50 Average
92,100.00 Current
170,000.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts ----1215
Avg. Estimate 001,698.593,442.99
Low Estimate 001,441.312,487
High Estimate 002,1814,808
Year Ago EPS ----3,0741,698.59

Revenue Estimate

Currency in KRW Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 441517
Avg. Estimate 171.93B180.97B698.39B904.27B
Low Estimate 168B173B667.6B792B
High Estimate 177.6B188.7B725.7B1.06T
Year Ago Sales 134B136.6B547.6B698.39B
Sales Growth (year/est) 28.31%32.48%27.54%29.48%

Earnings History

Currency in KRW 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 107.24123.44197.19267.84
EPS Actual 3591232,428--
Difference 251.76-0.442,230.81--
Surprise % 234.76%-0.36%1,131.30%--

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 001,698.593,442.99
7 Days Ago 001,876.363,468.22
30 Days Ago 001,876.363,468.22
60 Days Ago 001,853.633,409.62
90 Days Ago 001,748.423,381.53

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----43
Up Last 30 Days ----43
Down Last 7 Days ----23
Down Last 30 Days ----23

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
326030.KS -----44.74%102.70%
S&P 500 13.17%3.05%8.05%13.75%

Related Tickers